Result : 109

Prion diseases

Prion diseases or subacute transmissible spongiform encephalopathies (TSE) are neurodegenerative diseases. The agent responsible for the disease and its transmission is a protein with an abnormal...
 Jean-Philippe Brandel. March 2025, page 65

Chemsex: a growing and evolving practice

Chemsex, the voluntary use of psychoactive substances to facilitate, initiate, increase, intensify or prolong sexual relations and performance, often involves multiple substance use. These include...
 Jean-Victor Blanc. March 2025, page 70

Marcel Proust and doctors

Jacques Rouëssé. March 2025, page 92

Bladder pain syndrome

Bladder pain syndrome (BPS), often associated with other pelvic pain syndromes, is defined as perceived chronic pain or discomfort related to the bladder, associated with other urinary symptoms...
 Shahed Borojeni, Benoit Peyronnet. June 2025, page 36

Irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common functional digestive disorder affecting 4 to 10% of the population, with a female gender predominance. Although it is a benign disease, it can sometimes...
 Jean-Marc Sabaté. June 2025, page 48

Pelvic-perineal muscle pain syndromes

The search for muscle pain in the lower abdominal, gluteal and perineal regions is part of the systematic clinical examination of all pelvic perineal pain. These points of muscle hypersensitivity...
 Véronique Bonniaud. June 2025, page 62

Living with… Kawasaki disease

 Alexandre Belot, Raphaël Darbon. June 2025, page 87

Recent developments in the treatment of ANCA-associated vasculitides

The treatment of antineutrophil cytoplasm antibody-associated (ANCA) vasculitis is based on induction therapy to achieve remission, followed by maintenance therapy to prevent relapse. Management...
 Xavier Puéchal. November 2025, page 43

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

The treatment of ANCA-associated vasculitides (AAV) is based on therapeutic strategies that achieve remission and significantly reduce the risk of relapse in most cases over the medium term....
 Alexandre Karras. November 2025, page 49